Logo image of ACHV

ACHIEVE LIFE SCIENCES INC (ACHV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ACHV - US0044685008 - Common Stock

5.42 USD
-0.07 (-1.28%)
Last: 1/21/2026, 8:00:00 PM
5.23 USD
-0.19 (-3.51%)
After Hours: 1/21/2026, 8:00:00 PM
Fundamental Rating

2

ACHV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While ACHV seems to be doing ok healthwise, there are quite some concerns on its profitability. ACHV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ACHV had negative earnings in the past year.
  • ACHV had a negative operating cash flow in the past year.
  • ACHV had negative earnings in each of the past 5 years.
  • ACHV had a negative operating cash flow in each of the past 5 years.
ACHV Yearly Net Income VS EBIT VS OCF VS FCFACHV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • The Return On Assets of ACHV (-100.59%) is worse than 74.86% of its industry peers.
  • ACHV has a worse Return On Equity (-155.72%) than 64.57% of its industry peers.
Industry RankSector Rank
ROA -100.59%
ROE -155.72%
ROIC N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACHV Yearly ROA, ROE, ROICACHV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

  • ACHV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHV Yearly Profit, Operating, Gross MarginsACHV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

4

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ACHV has more shares outstanding
  • The number of shares outstanding for ACHV has been increased compared to 5 years ago.
  • ACHV has a better debt/assets ratio than last year.
ACHV Yearly Shares OutstandingACHV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACHV Yearly Total Debt VS Total AssetsACHV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • ACHV has an Altman-Z score of 0.40. This is a bad value and indicates that ACHV is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 0.40, ACHV is doing good in the industry, outperforming 61.90% of the companies in the same industry.
  • ACHV has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • ACHV has a Debt to Equity ratio of 0.26. This is in the lower half of the industry: ACHV underperforms 66.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACCN/A
WACCN/A
ACHV Yearly LT Debt VS Equity VS FCFACHV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 5.14 indicates that ACHV has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.14, ACHV is in line with its industry, outperforming 57.33% of the companies in the same industry.
  • ACHV has a Quick Ratio of 5.14. This indicates that ACHV is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 5.14, ACHV is in line with its industry, outperforming 58.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.14
Quick Ratio 5.14
ACHV Yearly Current Assets VS Current LiabilitesACHV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

  • ACHV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.12%.
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 28.44% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3.94%
EPS Next 2Y3.65%
EPS Next 3Y23.69%
EPS Next 5Y28.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACHV Yearly Revenue VS EstimatesACHV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2021 2022 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
ACHV Yearly EPS VS EstimatesACHV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K -2K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ACHV. In the last year negative earnings were reported.
  • Also next year ACHV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACHV Price Earnings VS Forward Price EarningsACHV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACHV Per share dataACHV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ACHV's earnings are expected to grow with 23.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.65%
EPS Next 3Y23.69%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for ACHV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ACHIEVE LIFE SCIENCES INC

NASDAQ:ACHV (1/21/2026, 8:00:00 PM)

After market: 5.23 -0.19 (-3.51%)

5.42

-0.07 (-1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)03-09
Inst Owners44.15%
Inst Owner Change-0.14%
Ins Owners4.54%
Ins Owner Change19.89%
Market Cap288.51M
Revenue(TTM)N/A
Net Income(TTM)-52.35M
Analysts81.54
Price Target15.68 (189.3%)
Short Float %12.96%
Short Ratio10.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.21%
Min EPS beat(2)-6.75%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-4.14%
Min EPS beat(4)-10.29%
Max EPS beat(4)0.34%
EPS beat(8)3
Avg EPS beat(8)-5.36%
EPS beat(12)6
Avg EPS beat(12)-0.04%
EPS beat(16)7
Avg EPS beat(16)-3.08%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.23%
PT rev (3m)0.27%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)-9.83%
EPS NY rev (1m)0.46%
EPS NY rev (3m)-3.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.58
P/tB 9.08
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0
BVpS0.63
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.59%
ROE -155.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.14
Quick Ratio 5.14
Altman-Z 0.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-3.94%
EPS Next 2Y3.65%
EPS Next 3Y23.69%
EPS Next 5Y28.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-30.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.12%
OCF growth 3YN/A
OCF growth 5YN/A

ACHIEVE LIFE SCIENCES INC / ACHV FAQ

What is the fundamental rating for ACHV stock?

ChartMill assigns a fundamental rating of 2 / 10 to ACHV.


What is the valuation status of ACHIEVE LIFE SCIENCES INC (ACHV) stock?

ChartMill assigns a valuation rating of 1 / 10 to ACHIEVE LIFE SCIENCES INC (ACHV). This can be considered as Overvalued.


What is the profitability of ACHV stock?

ACHIEVE LIFE SCIENCES INC (ACHV) has a profitability rating of 0 / 10.